Sinco Pharmaceuticals Holdings Limited (HKG:6833)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1700
0.00 (0.00%)
Mar 3, 2026, 3:53 PM HKT

HKG:6833 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3464004885393,517499
Market Cap Growth
-25.44%-17.92%-9.43%-84.68%604.67%-19.18%
Enterprise Value
3404571534053,596507
Last Close Price
0.170.190.230.251.780.28
PE Ratio
7.668.9510.466.8621.213.56
Forward PE
-15.2815.2815.2815.2815.28
PS Ratio
0.130.130.170.211.420.21
PB Ratio
0.460.570.710.797.642.56
P/TBV Ratio
0.560.640.810.917.642.54
P/FCF Ratio
--1.3721.2810.153.07
P/OCF Ratio
14.43-1.256.359.373.06
EV/Sales Ratio
0.120.150.060.161.450.21
EV/EBITDA Ratio
2.523.241.093.2914.822.81
EV/EBIT Ratio
3.293.771.203.5415.212.97
EV/FCF Ratio
-69.61-0.4315.9910.383.12
Debt / Equity Ratio
0.330.530.400.320.910.50
Debt / EBITDA Ratio
1.852.531.891.711.710.54
Debt / FCF Ratio
--0.788.591.210.60
Net Debt / Equity Ratio
-0.010.06-0.30-0.230.04-0.37
Net Debt / EBITDA Ratio
-0.040.32-1.46-1.250.08-0.40
Net Debt / FCF Ratio
1.06-0.16-0.57-6.110.05-0.45
Asset Turnover
1.351.451.531.711.631.97
Inventory Turnover
14.0310.9522.4425.8110.876.97
Quick Ratio
0.850.740.840.910.760.74
Current Ratio
1.161.141.161.291.341.01
Return on Equity (ROE)
6.41%6.51%6.88%14.19%50.09%112.13%
Return on Assets (ROA)
3.19%3.66%4.39%4.76%9.69%8.62%
Return on Invested Capital (ROIC)
8.77%8.45%10.87%16.53%63.09%215.42%
Return on Capital Employed (ROCE)
13.80%17.00%17.70%16.00%38.00%55.00%
Earnings Yield
13.50%11.17%9.56%14.58%4.71%28.11%
FCF Yield
-1.42%-71.22%73.19%4.70%9.85%32.58%
Dividend Yield
1.18%1.03%1.67%3.92%--
Payout Ratio
8.62%17.17%42.77%---
Buyback Yield / Dilution
0.04%--0.07%-16.93%-2.69%-
Total Shareholder Return
1.22%1.03%1.61%-13.01%-2.69%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.